|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,945.84 |
3.23% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$65,184.30 |
3.01% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$53,645.91 |
2.48% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,848.68 |
2.35% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$50,407.04 |
2.33% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,156.70 |
2.23% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$47,954.79 |
2.22% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$47,938.60 |
2.21% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,625.27 |
2.20% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,259.08 |
2.18% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,184.00 |
2.18% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,876.15 |
2.17% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$46,052.36 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,957.27 |
2.12% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,924.01 |
2.08% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,790.90 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,658.25 |
2.06% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$44,387.88 |
2.05% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,269.24 |
2.05% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,961.35 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$43,502.35 |
2.01% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$43,497.93 |
2.01% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$43,161.40 |
1.99% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,608.64 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$42,645.50 |
1.97% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,656.40 |
1.97% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$42,395.17 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,796.96 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,273.32 |
1.91% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,283.75 |
1.91% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$41,065.44 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,615.90 |
1.88% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$40,756.27 |
1.88% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$39,934.61 |
1.85% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,183.32 |
1.81% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,173.51 |
1.81% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,352.19 |
1.77% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,201.16 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$38,147.97 |
1.76% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,625.00 |
1.74% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,561.30 |
1.74% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,758.02 |
1.74% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$37,583.99 |
1.74% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,570.04 |
1.74% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,919.22 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$36,049.28 |
1.67% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$35,927.03 |
1.66% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$35,338.07 |
1.63% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,418.70 |
1.59% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,792.90 |
1.52% |
| US Dollar |
$USD |
|
2,483 |
$2,483.10 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|